ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 109 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,702,115 | +1439.7% | 320,549 | +2663.4% | 0.00% | – |
| Q2 2023 | $110,548 | +1024.1% | 11,600 | -98.3% | 0.00% | -100.0% |
| Q4 2022 | $9,834 | -99.4% | 664,447 | +673.5% | 0.01% | +400.0% |
| Q3 2022 | $1,641,000 | -14.9% | 85,897 | -14.2% | 0.00% | 0.0% |
| Q1 2022 | $1,928,000 | +163.7% | 100,126 | +227.0% | 0.00% | – |
| Q3 2021 | $731,000 | +67.3% | 30,618 | +102.9% | 0.00% | – |
| Q1 2021 | $437,000 | -90.3% | 15,093 | -90.6% | 0.00% | -100.0% |
| Q4 2020 | $4,503,000 | +401.4% | 160,094 | +422.5% | 0.00% | +200.0% |
| Q3 2020 | $898,000 | +14.5% | 30,642 | +18.1% | 0.00% | 0.0% |
| Q2 2020 | $784,000 | +121.5% | 25,939 | +118.3% | 0.00% | 0.0% |
| Q1 2020 | $354,000 | – | 11,884 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,684,232 | $46,113,272 | 3.06% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,105,309 | $5,869,191 | 2.34% |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $15,930,000 | 1.78% |
| Sio Capital Management, LLC | 635,969 | $3,376,995 | 1.04% |
| Rubric Capital Management LP | 5,034,530 | $26,733,354 | 1.00% |
| Tejara Capital Ltd | 309,179 | $1,641,740 | 0.93% |
| AlphaCentric Advisors LLC | 165,000 | $876,150 | 0.50% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,135,227 | $6,028,055 | 0.33% |
| Orbimed Advisors | 1,914,479 | $10,165,883 | 0.22% |
| Two Seas Capital LP | 164,807 | $875,125 | 0.18% |